We are live on
!
Find out more
UOC
UBS O'Connor Portfolio holdings
AUM
$3.76B
1-Year Est. Return
62.41%
This Fund
S&P 500
This Quarter
Est. Return
+12.37%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$11.2B
AUM Growth
+$4.26B
(+61%)
Cap. Flow
+$3.37B
Cap. Flow
% of AUM
30.06%
Top 10 Holdings %
Top 10 Hldgs %
50.61%
Holding
1,169
New
360
Increased
131
Reduced
115
Closed
294
Avg Time Held Equity + Options
1.3
quarters
Top 10 Avg Time Held Equity + Options
0.9
quarters
Top 20 Avg Time Held Equity + Options
0.9
quarters
Avg Time Held Equity only
1.2
quarters
Top 10 Avg Time Held Equity only
0.9
quarters
Top 20 Avg Time Held Equity only
0.9
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPD
PPD, Inc. Common Stock
PPD
|
+$645M |
| 2 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$539M |
| 3 |
MXIM
Maxim Integrated Products
MXIM
|
+$525M |
| 4 |
VER
VEREIT, Inc.
VER
|
+$520M |
| 5 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$491M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$475M |
| 2 |
RP
RealPage, Inc.
RP
|
+$281M |
| 3 |
GRUB
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
|
+$209M |
| 4 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
+$170M |
| 5 |
CLGX
Corelogic, Inc.
CLGX
|
+$160M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.69% |
| 2 | Healthcare | 19.01% |
| 3 | Financials | 14.31% |
| 4 | Real Estate | 10.94% |
| 5 | Communication Services | 7.66% |
Similar funds
FNBT
ACI
RC
A
CGL
CB
JCM
MPM
UBS O'Connor's Q2 2021 Portfolio in Review
As of Q2 2021, UBS O'Connor held 1,169 positions worth $11.2B, up 61% from $6.94B the previous quarter. Its ten largest holdings account for 51% of the portfolio.
UBS O'Connor deployed $3.37B of net new capital in Q2 2021, opening 360 new positions and adding to 131 existing holdings. Its largest new stake was PPD, Inc. Common Stock: 14,271,048 shares worth $658M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was MasTec, an estimated $7.65M trimmed.
- UBS O'Connor's largest Q2 2021 buy was PPD, Inc. Common Stock: 14,271,048 shares worth $658M.
- UBS O'Connor added most to Maxim Integrated Products in Q2 2021, an estimated $525M increase.
- UBS O'Connor's biggest Q2 2021 reduction was MasTec, cutting an estimated $7.65M.
- UBS O'Connor fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $475M.
- UBS O'Connor's ten largest holdings make up 51% of its $11.2B portfolio in Q2 2021.
- UBS O'Connor opened 360 new positions and closed 294 in Q2 2021.
- UBS O'Connor's portfolio value rose 61% quarter-over-quarter to $11.2B.
Based on UBS O'Connor's 13F filing for Q2 2021, filed 13 Aug 2021.